1. Home
  2. VIRC vs GANX Comparison

VIRC vs GANX Comparison

Compare VIRC & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.16

Market Cap

114.0M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.97

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
GANX
Founded
1950
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
100.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
VIRC
GANX
Price
$6.16
$2.97
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.00
AVG Volume (30 Days)
33.8K
593.5K
Earning Date
03-20-2026
01-01-0001
Dividend Yield
1.58%
N/A
EPS Growth
N/A
47.95
EPS
0.61
N/A
Revenue
$266,240,000.00
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.73
N/A
P/E Ratio
$10.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.00
$1.41
52 Week High
$10.62
$4.34

Technical Indicators

Market Signals
Indicator
VIRC
GANX
Relative Strength Index (RSI) 43.85 69.18
Support Level $6.08 $1.60
Resistance Level $6.64 $3.06
Average True Range (ATR) 0.17 0.23
MACD 0.00 0.10
Stochastic Oscillator 28.57 99.59

Price Performance

Historical Comparison
VIRC
GANX

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: